Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
- PMID: 23825116
- PMCID: PMC3730691
- DOI: 10.1098/rsif.2013.0414
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
Abstract
Dengue, a mosquito-borne virus of humans, infects over 50 million people annually. Infection with any of the four dengue serotypes induces protective immunity to that serotype, but does not confer long-term protection against infection by other serotypes. The immunological interactions between serotypes are of central importance in understanding epidemiological dynamics and anticipating the impact of dengue vaccines. We analysed a 38-year time series with 12 197 serotyped dengue infections from a hospital in Bangkok, Thailand. Using novel mechanistic models to represent different hypothesized immune interactions between serotypes, we found strong evidence that infection with dengue provides substantial short-term cross-protection against other serotypes (approx. 1-3 years). This is the first quantitative evidence that short-term cross-protection exists since human experimental infection studies performed in the 1950s. These findings will impact strategies for designing dengue vaccine studies, future multi-strain modelling efforts, and our understanding of evolutionary pressures in multi-strain disease systems.
Keywords: cross-protection; dengue; infectious disease modelling; time-series models.
Figures
References
-
- Gill PW, Murphy AM. 1977. Naturally acquired immunity to influenza type a: a further prospective study. Med. J. Aust. 2, 761–765 - PubMed
-
- Muelenaer PM, Henderson FW, Hemming VG, Walsh EE, Anderson LJ, Prince GA, Murphy BR. 1991. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J. Infect. Dis. 164, 15–2110.1093/infdis/164.1.15 (doi:10.1093/infdis/164.1.15) - DOI - DOI - PubMed
-
- Sabchareon A, et al. 2012. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet 380, 1559–156710.1016/S0140-6736(12)61428-7 (doi:10.1016/S0140-6736(12)61428-7) - DOI - DOI - PubMed
-
- Ferguson NM, Galvani AP, Bush RM. 2003. Ecological and immunological determinants of influenza evolution. Nature 422, 428–43310.1038/nature01509 (doi:10.1038/nature01509) - DOI - DOI - PubMed
-
- Cobey S, Lipsitch M. 2012. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335, 1376–138010.1126/science.1215947 (doi:10.1126/science.1215947) - DOI - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical